#SCM16: Eculizumab and Bortezomib Combination – Can It Work?
Dr. Yougandhar Akula (YA), from the University of Mississippi in Jackson, Mississippi, discusses his abstract for the National Kidney Foundation’s 2016 Spring Clinical [...]
transplantation
Paying Kidney Donors — Necessary or Not?
There is a great shortage of transplantable kidneys based on the number of transplant candidates awaiting organs in the United States. Some thought leaders have proposed [...]
Test Your Knowledge: Immunology and Transplantation
AJKD recently published a Core Curriculum by Dr. Donald Hricik on transplant immunology and immunosuppression. The following questions based on the article will test your [...]
Gout After Living Kidney Donation: Another Unrecognized Risk?
In an article recently published in AJKD, Lam et al describe the risk of gout in 1988 living kidney donors compared to a matched cohort of 19,880 non-donors over a median [...]
ATC2015: Belatacept in Kidney Transplantation
There were several abstracts presented about outcomes in patients treated with belatacept, a recently FDA-approved immunosuppressive agent that blocks T-cell activation. [...]
ATC2015: Antibodies and Allograft Injury
There were two fascinating talks about the use of C1q modified Luminex assay to assess for complement fixing antibodies both before and after kidney transplantation. Prior [...]
ATC2015: Biomarkers in Transplantation
Biomarkers are always a hot topic in transplantation. At the ATC, Dr. Barbara Murphy, from the Icahn School of Medicine at Mt. Sinai, gave an intriguing discussion on [...]
ATC2015: Blocking B7 in Kidney Transplantation, Is It Effective in Preventing FSGS?
The American Transplant Congress (ATC) is the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST) and [...]
The Expanding Role of Proteasome Inhibitors in Treatment of Renal Diseases
Invited commentary by Dr. Parmjeet Randhawa Bortezomib is a proteasome inhibitor initially licensed for use in patients with refractory multiple myeloma. More recently, [...]
Paraprotein Mediated Disease Following Kidney Transplantation
In a recent article published by AJKD, Batal et al describe a patient whose kidney allograft biopsy 7 years after transplantation revealed IgG1 kappa monoclonal glomerular [...]